Wells Fargo Reacts To Regulus News Of FDA Request For Info Regarding Clinical Hold
July 28, 2016 at 16:17 PM EDT
Wells Fargo maintained its Outperform rating on shares of Regulus Therapeutics, Inc. (NASDAQ: RGLS) but lowered its valuation range ...
